'Idiopathic pulmonary fibrosis ipf' presentation slideshows

Elisabetta Cocconcelli

570 views • 30 slides

Idiopathic Pulmonary Fibrosis Standards of Care & Investigational Therapies

526 views • 28 slides

Idiopathic Pulmonary Fibrosis Treatment Market Seeking Growth from Emerging Study Drivers, Restraints and Forecast 2026

Lack of awareness and availability of proper treatment is expected to hinder the idiopathic pulmonary fibrosis market growth. According to National Center for Biotechnology Information (NCBI) 2017 report, 54% patients do not receive any antifibrotic treatment in Europe.

87 views • 8 slides

Laminar Growth to be Witnessed by Current Trend Of Idiopathic Pulmonary Fibrosis Treatment Market

Lack of awareness and availability of proper treatment is expected to hinder the idiopathic pulmonary fibrosis market growth. According to National Center for Biotechnology Information (NCBI) 2017 report, 54% patients do not receive any antifibrotic treatment in Europe.

84 views • 8 slides

The Effectiveness of Pulmonary Rehabilitation in Comparison Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Interstitial lung diseases (ILD) represent some of the most severe chronic afflictions in the field of pulmonology. Despite years of study and medical innovation, survival rates and quality of life scores of ILD patients remain low with a comprehensive treatment yet to be found.

54 views • 5 slides